OrthoPediatrics (KIDS) Competitors

LeMaitre Vascular (NASDAQ:LMAT) and OrthoPediatrics (NASDAQ:KIDS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, community ranking, institutional ownership, valuation, media sentiment and dividends.

Which has more risk and volatility, LMAT or KIDS?

LeMaitre Vascular has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of LMAT or KIDS?

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 10.8% of LeMaitre Vascular shares are owned by insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has preferable valuation and earnings, LMAT or KIDS?

LeMaitre Vascular has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$219.86M	9.32	$30.10M	$1.94	46.77
OrthoPediatrics	$204.73M	2.47	-$20.97M	-$1.63	-12.77

Is LMAT or KIDS more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to OrthoPediatrics' net margin of -15.00%. LeMaitre Vascular's return on equity of 13.15% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	19.40%	13.15%	11.47%
OrthoPediatrics	-15.00%	-5.78%	-4.80%

Does the MarketBeat Community prefer LMAT or KIDS?

LeMaitre Vascular received 200 more outperform votes than OrthoPediatrics when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 64.42% of users gave OrthoPediatrics an outperform vote.

Company	Underperform	Outperform
LeMaitre Vascular	Outperform Votes 515 70.45%	Underperform Votes 216 29.55%
OrthoPediatrics	Outperform Votes 315 64.42%	Underperform Votes 174 35.58%

Do analysts recommend LMAT or KIDS?

LeMaitre Vascular presently has a consensus target price of $98.14, suggesting a potential upside of 8.16%. OrthoPediatrics has a consensus target price of $37.00, suggesting a potential upside of 77.71%. Given OrthoPediatrics' stronger consensus rating and higher possible upside, analysts clearly believe OrthoPediatrics is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.63
OrthoPediatrics	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Does the media prefer LMAT or KIDS?

In the previous week, LeMaitre Vascular had 8 more articles in the media than OrthoPediatrics. MarketBeat recorded 11 mentions for LeMaitre Vascular and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.71 beat LeMaitre Vascular's score of 1.17 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

LeMaitre Vascular beats OrthoPediatrics on 13 of the 19 factors compared between the two stocks.